Investment
Features
FeesSafety
Academy
More
Pluang+

StarkWare unveils quantum-resistant Bitcoin method without protocol changes but with high transaction costs

Protocol Fundamentals
10 Apr 2026
Blockonomi
View Source
Neutral
pluang ai news

StarkWare has introduced a quantum-resistant security framework for Bitcoin that works within the current protocol, avoiding any need for network upgrades or consensus changes. This approach replaces vulnerable elliptic curve signatures with a hash-based cryptographic model that can withstand quantum attacks, enhancing Bitcoin's security against future quantum computers. However, the method requires intensive GPU processing, making transactions costly—estimated between $75 and $150 each—and is suited mainly for high-value transfers. While this solution protects new transactions, it does not secure legacy Bitcoin addresses and serves as a temporary measure while more permanent protocol upgrades are developed.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Klarna's growth driven by strong financing, low-cost funding, and expanding customer base despite market volatility risks.

Klarna's growth driven by strong financing, low-cost funding, and expanding customer base despite market volatility risks.

Klarna benefits from maturing financing cohorts, low-cost deposit funding, and prudent risk management, leading to increased transaction margins and net interest income. This supports their growth strategy, reflected in accelerating gross merchandise...

Analyst Insights
Bullish
4 hours ago
Low-cost processing could double gallium grades at G50's Golconda project, with gold and silver as co-products.

Low-cost processing could double gallium grades at G50's Golconda project, with gold and silver as co-products.

G50 Corp announced that Phase 2 metallurgical tests at its Golconda project in Arizona show low-cost processing could double gallium grades while also producing gold and silver. This breakthrough reduces risks in gallium extraction, a critical minera...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App